In the first reported case of the autoinflammatory VEXAS syndrome in South Africa, J Damelin, J Jacobson, C Bam, L Pillay and ...

Women who accidentally fall pregnant while taking a GLP-1 treatment for diabetes or weight loss are not at increased risk of ...

This week on Why Did I Become A Doctor?, in partnership with MedicalBrief, Dr Suhayl Essa talks medicine, comedy, burnout, ...

Under a new health accountability framework endorsed by the 81st UN General Assembly (UNGA) last month in New York, African governments have committed to subjecting their progress on maternal and ...

The row over Gauteng Emergency Medical Services (EMS) staff contracts and overtime is unresolved, with 21 people being charged and facing disciplinary action, reports The Citizen. The dispute is ...

Women with peripheral artery disease are less likely than men to receive a timely diagnosis or recommended care, which can further jeopardise cardiovascular health, warn experts in The Washington Post ...

In efforts to sustain the use of GLP-1 drugs by its members – most of whom stop claiming for the treatment within six months – Discovery’s rewards scheme Vitality is stepping up its support, saying ...

Africa has reached an important moment in its immunisation journey, with coverage not rising fast enough to keep pace with population growth; persistent inequities, and a growing number of vaccines.

If R182m meant for an already buckling health system can be poured into PR with so few checks, imagine the risks when the NHI becomes the country’s single, centralised purchaser of healthcare, writes ...

Merck has announced that it will no longer manufacture or market the antibacterial combination drug Recarbrio as “part of an ongoing review of its portfolio and unrelated to any product safety or ...